Rudd; Michael T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rudd; Michael T..The latest application filed is for "pyrrolidine orexin receptor agonists".

Company Profile

18.35.37

Rudd; Michael T. - Collegeville PA
RUDD; Michael T. - West Point PA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,339,156 - Acton, III , et al. May 24, 2	2022-05-24
Pyrrolidine Orexin Receptor Agonists App 20220144771 - Bogen; Stephane L. ; et al.	2022-05-12
Bicycloheptane Pyrrolidine Orexin Receptor Agonists App 20220056017 - BOGEN; Stephane L. ; et al.	2022-02-24
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20210380580 - ACTON, III; John J. ; et al.	2021-12-09
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 11,149,036 - Acton, III , et al. October 19, 2	2021-10-19
Phosphinic Amide Prodrugs Of Tenofovir App 20210260082 - De Lera Ruiz; Manuel ; et al.	2021-08-26
5-alkyl pyrrolidine orexin receptor agonists Grant 11,098,029 - Bogen , et al. August 24, 2	2021-08-24
5-(pyridin-3-yl)oxazole allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,981,902 - Bao , et al. April 20, 2	2021-04-20
N-aryl and N-heteroaryl piperidine derivatives as liver X receptor beta agonists, compositions, and their use Grant 10,961,215 - Rudd , et al. March 30, 2	2021-03-30
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,933,056 - Acton, III , et al. March 2, 2	2021-03-02
Piperidine derivatives as liver X receptor beta agonists, compositions, and their use Grant 10,894,775 - Rudd , et al. January 19, 2	2021-01-19
Homobispiperidinyl derivatives as liver X receptor beta agonists, compositions and their use Grant 10,752,587 - Rudd , et al. A	2020-08-25
5-alkyl Pyrrolidine Orexin Receptor Agonists App 20200255403 - Kind Code	2020-08-13
Aryl And Heteroaryl Ether Derivatives As Liver X Receptor Beta Agonists, Compositions, And Their Use App 20200247754 - Kind Code	2020-08-06
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200207758 - ACTON, III; John J. ; et al.	2020-07-02
5-(pyridin-3-yl)oxazole Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200109137 - BAO; Jianming ; et al.	2020-04-09
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20200069671 - Acton, III; John J. ; et al.	2020-03-05
N-aryl And N-heteroaryl Piperidine Derivatives As Liver X Receptor Beta Agonists, Compositions, And Their Use App 20200039951 - Rudd; Michael T. ; et al.	2020-02-06
3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor Grant 10,512,638 - Rudd , et al. Dec	2019-12-24
Piperidine Derivatives As Liver X Receptor Beta Agonists, Compositions, And Their Use App 20190375716 - Rudd; Michael T. ; et al.	2019-12-12
Cyanopyridine derivatives as liver X receptor beta agonists, compositions, and their use Grant 10,239,849 - Rudd , et al.	2019-03-26
3-(1h-pyrazol-4-yl)pyridine Allosteric Modulators Of The M4 Muscarinic Acetylcholine Receptor App 20190000824 - Acton, III; John J. ; et al.	2019-01-03
Homobispiperidinyl Derivatives As Liver X Receptor Beta Agonists, Compositions And Their Use App 20180354901 - Rudd; Michael T. ; et al.	2018-12-13
Cyanopyridine Derivatives as Liver X Receptor Beta Agonists, Compositions, and Their Use App 20180327374 - Rudd; Michael T. ; et al.	2018-11-15
HCV NS3 protease inhibitors Grant 9,738,661 - Liverton , et al. August 22, 2	2017-08-22
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 9,663,506 - Bungard , et al. May 30, 2	2017-05-30
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 9,636,337 - Bungard , et al. May 2, 2	2017-05-02
Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGluR2-Negative Allosteric Modulators, Compositions, and Their Use App 20160158217 - Bungard; Christopher James ; et al.	2016-06-09
Quinoline Carboxamide and Quinoline Carbonitrile Derivatives as mGluR2-Negative Allosteric Modulators, Compositions, and Their Use App 20160159744 - Bungard; Christopher James ; et al.	2016-06-09
HCV NS3 protease inhibitors Grant 9,328,138 - Rudd , et al. May 3, 2	2016-05-03
Quinoline carboxamide and quinoline carbonitrile derivatives as mGluR2-negative allosteric modulators, compositions, and their use Grant 9,278,960 - Bungard , et al. March 8, 2	2016-03-08
HCV NS3 Protease Inhibitors App 20150266897 - Liverton; Nigel J. ; et al.	2015-09-24
Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitors Grant 9,102,673 - Hanney , et al. August 11, 2	2015-08-11
Macrocyclic compounds as antiviral agents Grant 8,927,569 - Harper , et al. January 6, 2	2015-01-06
QUINOLINE CARBOXAMIDE AND QUINOLINE CARBONITRILE DERIVATIVES AS mGluR2-NEGATIVE ALLOSTERIC MODULATORS, COMPOSITIONS, AND THEIR USE App 20140309227 - Bungard; Christopher James ; et al.	2014-10-16
Hcv Ns3 Protease Inhibitors App 20140296136 - Rudd; Michael T. ; et al.	2014-10-02
Hepatitis C virus NS3 protease inhibitors Grant 8,828,930 - Liverton , et al. September 9, 2	2014-09-09
TrkA KINASE INHIBITORS, COMPOSITIONS AND METHODS THEREOF App 20140155413 - Hanney; Barbara ; et al.	2014-06-05
Therapeutic compounds Grant 8,591,878 - McCauley , et al. November 26, 2	2013-11-26
Hcv Ns3 Protease Inhibitors App 20130178413 - McCauley; John A. ; et al.	2013-07-11
HCV NS3 protease inhibitors Grant 8,461,107 - Liverton , et al. June 11, 2	2013-06-11
HCV NS3 protease inhibitors Grant 8,377,874 - Liverton , et al. February 19, 2	2013-02-19
HCV NS3 protease inhibitors Grant 8,309,540 - Liverton , et al. November 13, 2	2012-11-13
HCV NS3 protease inhibitors Grant 8,278,322 - Holloway , et al. October 2, 2	2012-10-02
HCV NS3 protease inhibitors Grant 8,216,999 - Holloway , et al. July 10, 2	2012-07-10
Hepatitis C Virus Ns3 Protease Inhibitors App 20120121624 - Liverton; Nigel J. ; et al.	2012-05-17
Hcv Ns3 Protease Inhibitors App 20110046161 - Liverton; Nigel J. ; et al.	2011-02-24
HCV NS3 Protease Inhibitors App 20110028494 - Holloway; M. Katharine ; et al.	2011-02-03
HCV NS3 protease inhibitors Grant 7,879,797 - Holloway , et al. February 1, 2	2011-02-01
Therapeutic Compounds App 20110002884 - McCauley; John A. ; et al.	2011-01-06
Macrocyclic Compounds As Antiviral Agents App 20100183551 - Harper; Steven ; et al.	2010-07-22
HCV NS3 Protease Inhibitors App 20100099695 - Liverton; Nigel J. ; et al.	2010-04-22
Hcv Ns3 Protease Inhibitors App 20100093779 - Liverton; Nigel J. ; et al.	2010-04-15
Hcv Ns3 Protease Inhibitors App 20090124661 - HOLLOWAY; M. Katharine ; et al.	2009-05-14
HCV NS3 protease inhibitors App 20090075869 - Holloway; M. Katharine ; et al.	2009-03-19
HCV NS3 protease inhibitors Grant 7,470,664 - Holloway , et al. December 30, 2	2008-12-30
HCV NS3 protease inhibitors App 20070027071 - Holloway; M. Katharine ; et al.	2007-02-01